India's Aurobindo Pharma hits over three-month low; US business still weak, Citi says

Aurobindo Pharma

10/02/2026 09:43

** Shares of Aurobindo Pharma ARBN.NS fall around 8% to 1,106 rupees, its lowest since Oct. 31

** Stock set for its worst day since November 2022

** Pharma co posts 7.6% rise in Q3 profit to 9.1 billion rupees; consol rev rises 8.4% y/y

** Citi Research says Q3 beat was largely driven by favourable currency, continued strength in Europe

** Adds, co's flagship US generics business remains subdued

** More than 5.4 mln shares traded, 4.5x their 30-day avg

** YTD, ARBN down to ~6%

 (Reporting by Brijesh Patel in Bengaluru)

 ((Brijesh.Patel1@thomsonreuters.com; Ph no. +91 9590227221;))